Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study
- Author
- RJ Sylvester, Willem Oosterlinck (UGent) and M O'Donnell
- Organization
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 55.72 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-526239
- MLA
- Sylvester, RJ, et al. “Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study.” JOURNAL OF UROLOGY, vol. 181, no. 1, ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, 2009, pp. 410–410, doi:10.1016/j.juro.2008.09.053.
- APA
- Sylvester, R., Oosterlinck, W., & O’Donnell, M. (2009). Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study. JOURNAL OF UROLOGY, 181(1), 410–410. https://doi.org/10.1016/j.juro.2008.09.053
- Chicago author-date
- Sylvester, RJ, Willem Oosterlinck, and M O’Donnell. 2009. “Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study.” JOURNAL OF UROLOGY 181 (1): 410–410. https://doi.org/10.1016/j.juro.2008.09.053.
- Chicago author-date (all authors)
- Sylvester, RJ, Willem Oosterlinck, and M O’Donnell. 2009. “Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study.” JOURNAL OF UROLOGY 181 (1): 410–410. doi:10.1016/j.juro.2008.09.053.
- Vancouver
- 1.Sylvester R, Oosterlinck W, O’Donnell M. Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study. JOURNAL OF UROLOGY. 2009;181(1):410–410.
- IEEE
- [1]R. Sylvester, W. Oosterlinck, and M. O’Donnell, “Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study,” JOURNAL OF UROLOGY, vol. 181, no. 1, pp. 410–410, 2009.
@article{526239, author = {{Sylvester, RJ and Oosterlinck, Willem and O'Donnell, M}}, issn = {{0022-5347}}, journal = {{JOURNAL OF UROLOGY}}, language = {{eng}}, number = {{1}}, pages = {{410--410}}, publisher = {{ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH}}, title = {{Re: Can Early Single Dose Instillation of Epirubicin Improve Bacillus Calmette-Guerin Efficacy in Patients With Nonmuscle Invasive High Risk Bladder Cancer? Results From a Prospective, Randomized, Double-Blind Controlled Study}}, url = {{http://doi.org/10.1016/j.juro.2008.09.053}}, volume = {{181}}, year = {{2009}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: